| Literature DB >> 34884826 |
Yasuyuki Nagasawa1, Ryota Nomura2, Taro Misaki3,4, Seigo Ito5, Shuhei Naka6, Kaoruko Wato2, Mieko Okunaka7, Maiko Watabe7, Katsuya Fushimi7,8, Kenzo Tsuzuki8, Michiyo Matsumoto-Nakano6, Kazuhiko Nakano2.
Abstract
IgA nephropathy (IgAN) has been considered to have a relationship with infection in the tonsil, because IgAN patients often manifest macro hematuria just after tonsillitis. In terms of oral-area infection, the red complex of periodontal bacteria (Porphyromonas gingivalis (P. gingivalis), Treponema denticol (T. denticola) and Tannerella forsythia (T. forsythia)) is important, but the relationship between these bacteria and IgAN remains unknown. In this study, the prevalence of the red complex of periodontal bacteria in tonsil was compared between IgAN and tonsillitis patients. The pathogenicity of IgAN induced by P. gingivalis was confirmed by the mice model treated with this bacterium. The prevalence of P. gingivalis and T. forsythia in IgAN patients was significantly higher than that in tonsillitis patients (p < 0.001 and p < 0.05, respectively). A total of 92% of tonsillitis patients were free from red complex bacteria, while only 48% of IgAN patients had any of these bacteria. Nasal administration of P. gingivalis in mice caused mesangial proliferation (p < 0.05 at days 28a nd 42; p < 0.01 at days 14 and 56) and IgA deposition (p < 0.001 at day 42 and 56 after administration). Scanning-electron-microscopic observation revealed that a high-density Electron-Dense Deposit was widely distributed in the mesangial region in the mice kidneys treated with P. gingivalis. These findings suggest that P. gingivalis is involved in the pathogenesis of IgAN.Entities:
Keywords: IgA nephropathy; Porphyromonas gingivalis; infection; mouse; oral bacteria; periodontal bacteria; tonsil
Mesh:
Substances:
Year: 2021 PMID: 34884826 PMCID: PMC8657970 DOI: 10.3390/ijms222313022
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Patients characteristics.
| IgAnephropathy | Habitual Tonsilitis |
| |||
|---|---|---|---|---|---|
| Age | 33 ± 14 | 27 ± 7 | <0.01 | ||
| Sex | 9 Male | 14 Female | 26 Male | 37 Female | NS |
| Height (cm) | 160 ± 10 | 162 ± 20 | NS | ||
| Weight (Kg) | 54 ± 11 | 62 ± 15 | <0.05 | ||
| Proteinuria (g/gCre) | 0.9 ± 1.1 | N/A | N/A | ||
N/A; Not available. NS; Not significant.
Primers for detection of bacteria-related periodontal diseases.
| Purpose | Sequence (5′-3′) | Size (bp) | Ref. |
|---|---|---|---|
|
| |||
|
| |||
| PA | AGA GTT TGA TCC TGG CTC AG | 315 | [ |
| PD | GTA TTA CCG CGG CTG CTG | ||
|
| |||
|
| CCG CAT ACA CTT GTA TTA TTG CAT GAT A | 267 | [ |
| AAG AAG TTT ACA ATC CTT AGG ACT GTC T | |||
|
| AAG GCG GTA GAG CCG CTC A | 311 | [ |
| AGC CGC TGT CGA AAA GCC CA | |||
|
| GCG TAT GTA ACC TGC CCG CA | 641 | [ |
| TGC TTC AGT GTC AGT TAT ACC T | |||
|
| TTT CGG AGC GTA AAC TCC TTT TC | 598 | [ |
| TTT CTG CAA GCA GAC ACT CTT |
Figure 1Prevalence of periodontal bacteria. Prevalence of red complex of periodontal bacteria (P. gingivalis, T. denticola and T. forsythia) and C. rectus in tonsils with IgA nephropathy and tonsillitis patients were shown. Prevalence of P. gingivalis in IgA nephropathy patients was significantly higher than that in tonsillitis (p < 0.001). Prevalence of T. forsythia in IgA nephropathy patients was also significantly higher than that in tonsillitis (p < 0.05).
Patient backgrounds with or without P. gingivalis and T. forsythia.
|
| |||
| (−) (N = 16) | (+) (N = 7) |
| |
| Protenuria (g/acre) | 1.1 ± 0.8 | 1.1+1.4 | NS |
| C3 (mg/dL) | 98.5 ± 4.5 | 100.7 ± 8.4 | NS |
| C4 (mg/dL) | 25.2 ± 1.6 | 22.7 ± 3.0 | NS |
| IgA (mg/dL) | 368 ± 49 | 398 ± 36 | NS |
|
| |||
| (−) (N = 18) | (+) (N = 5) |
| |
| Protenuria (g/gcre) | 1.1 ± 0.3 | 1.1 ± 0.1 | NS |
| C3 (mg/dL) | 98.5 ± 4.5 | 99.5 ± 4.7 | NS |
| C4 (mg/dL) | 23.4 ± 1.6 | 30.0 ± 6.0 | NS |
| IgA (mg/dL) | 380 ± 33 | 384 ± 148 | NS |
NS: Not significant.
Figure 2Prevalence of numbers of periodontal bacteria out of three red complex of bacteria. Overall, 92.0% of tonsillitis patients were free from red complex of periodontal bacteria, while 52.1% of tonsillitis patients were free from those bacteria; 43.4% of IgA nephropathy patients were suffering from one periodontal bacterium, while only 6.3% of tonsillitis patents had one from red complex of periodontal bacteria. The distribution of the number of periodontal bacteria in IgA nephropathy patients was significantly different to that in tonsillitis patients (p < 0.001).
Figure 3Prevalence of IgA patients with strong galactose-deficient IgA1 (Gd-IgA1) staining in the kidney biopsy specimen. Prevalence of IgA patients with strong Gd-IaA1 staining in the kidney biopsy specimen in IgA patients with P. gingivalis tended to be higher than that in IgA patients without P. gingivalis.
Figure 4Numbers of mesangial proliferative glomeruli in 50 observed glomeruli in mice treated with P. gingivalis or saline (control). Glomeruli were evaluated by PAS staining. Each group consists of 10 mice. Numbers of mesangial proliferative glomeruli in 50 observed glomeruli in mice treated with P. gingivalis were significantly higher than those in control mice at day 14 (p < 0.01), at day 28 (p < 0.05), at day 42 (p < 0.05) and at day 56 (p < 0.01) after treatment of bacteria.
Figure 5Typical image of IgA immune-fluorescence staining in mice IgA nephropathy model treated with P. gingivalis. (A) None of the IgA immune-fluorescence stainings in control mice was observed. (B) Positive immune-fluorescence staining was observed in mice treated with P. gingivalis at day 56 after beginning treatment. IgA staining was observed in mesangial area in glomeruli.
Figure 6Prevalence of mice with positive IgA immune-fluorescence staining. In each mouse treated with P. gingivalis or saline (control) via nasal administration, IgA immune-fluorescence staining in glomeruli was observed under same condition. Each group consists of 10 mice. Numbers of mice with IgA immune-fluorescence staining treated with P. gingivalis were significantly higher than those of control mice at day 42 (p < 0.01), at day 42 and at day 56 (p < 0.01) after treatment of bacteria.
Figure 7Typical images of immune deposit in mesangial area of mice glomeruli treated with P. gingivalis at day 56 after treatment of bacteria, as observed by transmission electron microscopy. Immune deposit in mesangial area of mice glomeruli treated with P. gingivalis at day 56 after treatment of bacteria is indicated by yellow circle: (A) ×700 magnification and (B) ×2000 magnification.